Skip to content
DataLookout
Menu

QoL COVID HBOTNCT06159309

Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients

StatusWithdrawn
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Active, Not Recruiting → Withdrawn Sponsor's reason: No funding secured to start study Show 5 more changesShow less
    • Enrollment target: estimated 200 to confirmed 0
    • Eligibility criteria expanded, about 4 words
    • Primary completion pushed from Jun 2025 to Dec 2025
    • Study completion pushed from Aug 2025 to Feb 2026
    • Study description shortened, about 15 words
  2. Notable Primary completion date: Feb 2024 to Jun 2025v3 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Aug 2024 to Aug 2025
    • Site details revised at 6 of 6 sites
    • Collaborators shortened, about 2 words
  3. Notable Primary endpoint revised
    • Study sites: 2 to 6
    • Secondary endpoints revised (5)
    v2
  4. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Quality of life 3 and 12 months
Timeframe: 3 and 12 months

Secondary (5)

Long Covid symptoms
Cognitive complaints
Work
Risk factors quality of life
Profile of non-responders versus responders

Arms and interventions

Long Covid patients

All post-COVID patients that are referred for hyperbaric oxygen (and that are eligible for treatment)

Other: Hyperbaric oxygen therapy

Sites

6 sites in 1 country